Armband: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|A protein involved in lipid metabolism}} | |||
{{Use dmy dates|date=October 2023}} | |||
'''Apolipoprotein A-II''' ('''ApoA-II''') is a protein that plays a significant role in the metabolism of lipids in the human body. It is the second most abundant protein component of [[high-density lipoprotein]] (HDL) particles, which are often referred to as "good cholesterol" due to their role in transporting cholesterol from the tissues back to the liver for excretion or re-utilization. | |||
== | ==Structure== | ||
Apolipoprotein A-II is a small protein composed of 77 amino acids. It is primarily synthesized in the liver and secreted into the bloodstream. The protein exists in plasma as a homodimer, meaning it forms a complex with another identical ApoA-II molecule. This dimerization is stabilized by a disulfide bond between the two monomers. | |||
==Function== | |||
ApoA-II is involved in the regulation of lipid metabolism. It plays a role in the stabilization of HDL particles and influences the activity of several enzymes involved in lipid metabolism, including [[lecithin–cholesterol acyltransferase]] (LCAT), which is crucial for the maturation of HDL particles. ApoA-II also affects the interaction of HDL with cellular receptors and other proteins involved in lipid transport. | |||
== | ==Genetics== | ||
The gene encoding apolipoprotein A-II is located on chromosome 1 in humans. Variations in this gene can influence the levels of ApoA-II in the blood and have been associated with differences in lipid metabolism and cardiovascular risk. | |||
== | ==Clinical Significance== | ||
Alterations in ApoA-II levels have been linked to various metabolic disorders. Elevated levels of ApoA-II have been associated with an increased risk of [[atherosclerosis]], while low levels may be linked to certain forms of [[dyslipidemia]]. Research is ongoing to better understand the role of ApoA-II in cardiovascular disease and its potential as a therapeutic target. | |||
== | ==Research== | ||
Studies on ApoA-II continue to explore its role in lipid metabolism and its potential impact on health. Researchers are investigating how ApoA-II interacts with other proteins and lipids in the bloodstream and its influence on the development of cardiovascular diseases. | |||
[[ | ==Related pages== | ||
[[ | * [[Apolipoprotein A-I]] | ||
[[ | * [[High-density lipoprotein]] | ||
* [[Lipid metabolism]] | |||
* [[Cardiovascular disease]] | |||
==Gallery== | |||
<gallery> | |||
File:PDB_1l6l_EBI.jpg|Structure of Apolipoprotein A-II | |||
</gallery> | |||
[[Category:Proteins]] | |||
[[Category:Lipid metabolism]] | |||
[[Category:Cardiovascular diseases]] | |||
Revision as of 18:54, 11 February 2025
A protein involved in lipid metabolism
Apolipoprotein A-II (ApoA-II) is a protein that plays a significant role in the metabolism of lipids in the human body. It is the second most abundant protein component of high-density lipoprotein (HDL) particles, which are often referred to as "good cholesterol" due to their role in transporting cholesterol from the tissues back to the liver for excretion or re-utilization.
Structure
Apolipoprotein A-II is a small protein composed of 77 amino acids. It is primarily synthesized in the liver and secreted into the bloodstream. The protein exists in plasma as a homodimer, meaning it forms a complex with another identical ApoA-II molecule. This dimerization is stabilized by a disulfide bond between the two monomers.
Function
ApoA-II is involved in the regulation of lipid metabolism. It plays a role in the stabilization of HDL particles and influences the activity of several enzymes involved in lipid metabolism, including lecithin–cholesterol acyltransferase (LCAT), which is crucial for the maturation of HDL particles. ApoA-II also affects the interaction of HDL with cellular receptors and other proteins involved in lipid transport.
Genetics
The gene encoding apolipoprotein A-II is located on chromosome 1 in humans. Variations in this gene can influence the levels of ApoA-II in the blood and have been associated with differences in lipid metabolism and cardiovascular risk.
Clinical Significance
Alterations in ApoA-II levels have been linked to various metabolic disorders. Elevated levels of ApoA-II have been associated with an increased risk of atherosclerosis, while low levels may be linked to certain forms of dyslipidemia. Research is ongoing to better understand the role of ApoA-II in cardiovascular disease and its potential as a therapeutic target.
Research
Studies on ApoA-II continue to explore its role in lipid metabolism and its potential impact on health. Researchers are investigating how ApoA-II interacts with other proteins and lipids in the bloodstream and its influence on the development of cardiovascular diseases.
Related pages
Gallery
-
Structure of Apolipoprotein A-II